Israel Englander Enlivex Therapeutics Ltd. Put Options Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ENLV
# of Institutions
30Shares Held
3.18MCall Options Held
44.3KPut Options Held
7.1K-
Armistice Capital, LLC New York, NY1.78MShares$2.14 Million0.03% of portfolio
-
Morgan Stanley New York, NY231KShares$276,8220.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny181KShares$217,5460.0% of portfolio
-
Jane Street Group, LLC New York, NY80.8KShares$96,9100.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il70.1KShares$84,1630.0% of portfolio
About Enlivex Therapeutics Ltd.
- Ticker ENLV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,403,200
- Market Cap $22.1M
- Description
- Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2...